Publications

Found 5 results
Filters: Author is M.M.G. Pimentel  [Clear All Filters]
2010
V. A. Genelhu, Francischetti, E. A., Duarte, S. F. P., Celoria, B. M. J., Oliveira, R. C., Cabello, P. H., and Pimentel, M. M. G., β3-adrenergic receptor polymorphism is related to cardiometabolic risk factors in obese Brazilian subjects, vol. 9, pp. 1392-1397, 2010.
Clement K, Vaisse C, Manning BS, Basdevant A, et al. (1995). Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333: 352-354. http://dx.doi.org/10.1056/NEJM199508103330605 PMid:7609752   Fujisawa T, Ikegami H, Yamato E, Hamada Y, et al. (1997). Trp64Arg mutation of β3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am. J. Hypertens. 10: 101-105. http://dx.doi.org/10.1016/S0895-7061(96)00297-X   Gagnon J, Mauriege P, Roy S, Sjostrom D, et al. (1996). The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J. Clin. Invest. 98: 2086-2093. http://dx.doi.org/10.1172/JCI119014 PMid:8903328 PMCid:507653   Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404 PMid:16157765   Kim-Motoyama H, Yasuda K, Yamaguchi T, Yamada N, et al. (1997). A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40: 469-472. http://dx.doi.org/10.1007/s001250050702 PMid:9112025   Masuo K, Katsuya T, Fu Y, Rakugi H, et al. (2005). Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 111: 3429-3434. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.519652 PMid:15956122   Melis MG, Secchi G, Brizzi P, Severino C, et al. (2002). The Trp64Arg beta3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects. Clin. Sci. 103: 397-402. PMid:12241539   Morcillo S, Cardona F, Rojo-Martinez G, Almaraz MC, et al. (2008). Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Clin. Endocrinol. 68: 102-107. http://dx.doi.org/10.1111/j.1365-2265.2007.03006.x PMid:17727676   Patel DA, Srinivasan SR, Xu JH, Chen W, et al. (2006). Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 55: 1551-1557. http://dx.doi.org/10.1016/j.metabol.2006.06.028 PMid:17046560   Vague J (1956). The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4: 20-34. PMid:13282851